Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.58 - $3.91 $11.4 Million - $17.3 Million
-4,418,836 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$2.77 - $4.05 $42,829 - $62,621
-15,462 Reduced 0.35%
4,418,836 $15 Million
Q2 2021

Aug 16, 2021

SELL
$1.71 - $4.14 $10,172 - $24,628
-5,949 Reduced 0.13%
4,434,298 $17 Million
Q1 2021

May 17, 2021

SELL
$0.85 - $5.27 $8.53 Million - $52.9 Million
-10,039,862 Reduced 69.34%
4,440,247 $11.7 Million
Q4 2020

Feb 16, 2021

SELL
$0.36 - $0.95 $28,067 - $74,065
-77,964 Reduced 0.54%
14,480,109 $12.6 Million
Q3 2020

Nov 16, 2020

SELL
$0.36 - $0.53 $116,466 - $171,464
-323,517 Reduced 2.17%
14,558,073 $5.64 Million
Q2 2020

Aug 14, 2020

SELL
$0.39 - $0.69 $232,811 - $411,897
-596,953 Reduced 3.86%
14,881,590 $5.8 Million
Q1 2020

May 15, 2020

SELL
$0.56 - $1.62 $169,267 - $489,666
-302,263 Reduced 1.92%
15,478,543 $9.81 Million
Q4 2019

Feb 14, 2020

SELL
$0.83 - $1.3 $231,869 - $363,169
-279,361 Reduced 1.74%
15,780,806 $14.5 Million
Q3 2019

Nov 14, 2019

SELL
$0.97 - $1.94 $920,588 - $1.84 Million
-949,060 Reduced 5.58%
16,060,167 $15.9 Million
Q2 2019

Aug 13, 2019

SELL
$1.81 - $2.45 $1.33 Million - $1.8 Million
-733,291 Reduced 4.13%
17,009,227 $34.7 Million
Q1 2019

May 17, 2019

SELL
$2.3 - $3.27 $462,150 - $657,057
-200,935 Reduced 1.12%
17,742,518 $43.5 Million
Q4 2018

Feb 14, 2019

SELL
$2.49 - $4.54 $453,314 - $826,525
-182,054 Reduced 1.0%
17,943,453 $46.5 Million
Q3 2018

Oct 30, 2018

SELL
$3.4 - $4.84 $364,228 - $518,489
-107,126 Reduced 0.59%
18,125,507 $86.5 Million
Q2 2018

Jul 31, 2018

BUY
$3.03 - $4.98 $55.2 Million - $90.8 Million
18,232,633 New
18,232,633 $74.9 Million

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $396M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.